|
Friday 31st January 2003 |
Text too small? |
The result ended a two-year run of losses for the company, in which Eric Watson's Cullen Investments owns a controlling 53% stake.
Revenue rose 58% to $27.1 million, with growth coming mainly from the company's entry into diagnostics. The aged care and rehabilitation divisions also turned in improved performances.
Managing director Alan Clarke said the 28% annualised revenue growth rate achieved since the company began its repositioning in 2000 was expected to continue into the 2004 financial year and beyond.
Interests costs fell 20% as a result of refinancing and debt reduction.
No comments yet
March 16th Morning Report
Metro Performance Glass FY26 Market Update
Devon Funds Morning Note - 13 March 2026
Devon Funds Morning Note - 12 March 2026
TCM - Financial Model
BRM - Scheme of Arrangement Update - NZ Commerce Commission
Devon Funds Morning Note - 11 March 2026
BGP - Full Year Results to 25 January 2026
BRM - Scheme of Arrangement Update - NZ Commerce Commission
The oil shock